Clinical trial
Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along…
NCT00332306 · Tuberculosis Research Centre, India, Other · Unknown status
Key facts
| NCT number | NCT00332306 |
|---|---|
| Title | Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment |
| Official title | Evaluation of Safety and Efficacy of Two Different Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment in Patients With HIV-1 and Tuberculosis |
| Lead sponsor | Tuberculosis Research Centre, India, Other |
| Collaborators | National AIDS Control Organisation Indian Council of Medical Research |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis, Human Immunodeficiency Virus Infections |
| Intervention type | Drug |
| Interventions | Didanosine, Lamivudine, Efavirenz, Nevirapine |
| Enrollment | 180 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2011 |
| First posted | Jun 1, 2006 |
| Last update posted | Oct 8, 2009 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: